Sign in
CompletedNo phase

Efficacy of ICU-VTE Scale in ICU Patients

Key facts

Who runs it
Lijuan Zhang
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
269 people enrolled
Started
1 May 2022
Ended
10 Dec 2023
Type of study
Observational
Record updated
8 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • patients age greater than or equal to 18 years
  • Patients or their family members agreed to the study and signed informed consent

Who cannot take part

  • Patients admitted to ICU with VTE diagnosis or diagnosed with VTE within 24 hours of admission to ICU
  • Use the therapeutic dose of anticoagulation before admission to ICU or within 24 hours in ICU
  • Expected ICU stay of less than 48 hours
  • Patients cannot obtain imaging data to confirm the presence of VTE during ICU admission

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Venous thromboembolism (VTE) is a common cause of morbidity and mortality among critically ill patients. No uniform standard model of VTE risk for critically ill patients was formatted by now. In 2020, Viarasilpa et al. developed the ICU⁃VTE rating table, mainly for ICU patients. However, it lacks validation. We examined and compared how well the ICU-VTE score predict and stratify VTE risk in comprehensive ICU patients.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of ICU-VTE Scale in Predicting Venous Thromboembolism in ICU Patients
Record updated
8 May 2024